Maria Castellanos, MD

Assistant Clinical Professor, Department of Pediatrics, UCSF

Cancer Center Program Membership

Pediatric Malignancies

Research Summary

Dr. Maria Castellanos is Assistant Clinical Professor in the Division of Pediatric Hematology Oncology at University of California, San Francisco. Her clinical interests include treating children with high-risk pediatric hematologic malignancies. Her research interests focuses in  evaluating geospatial, racial, and ethnic disparities in pediatric cancers, with a specific focus in pediatric leukemias in the LatinX pediatric patient population. 


University of Nevada Las Vegas, Las Vegas, NV, BS, 2005-2010, Cell & Molecular Biology Howard University College of Medicine, Washington, D.C., MD, 2010-2014, Medicine Stanford University, Palo Alto, CA, 2014-2017, Pediatrics Residency Baylor College of Medicine, Houston, TX, 2018-2021, Pediatric Hematology & Oncology Fellowship

Honors & Awards

  • 2008
    NIH IDeA Network for Biomedical Research Excellence Research Scholarship
  • 2009
    NSF Research Experience for Undergraduates-Microbiology Research Scholarship
  • 2015-2017
    Stanford Society of Physician Scholars
  • 2016-2017
    New Century Scholar, Academic Pediatric Association
  • 2019
    Center of Excellence in Health Equity, Training, and Research Clinical Fellow Scholar
  • 2021
    Choosing Wisely Champion, American Society of Hematology Committee on Quality
  • 2021
    Quality Award of Cancer and Hematology Award, Texas Children’s Hospital
  • 2022
    Award of Excellence for Panel Presentation at Pediatric Grand Rounds, Baylor College of Medicine

Selected Publications

  • Castellanos MI, Oluyomi A, Chambers T, Gramatges MM, Winestone L, Lupo P, Scheurer ME.  Ethnic Disparities in Childhood Leukemia Survival by Border Residence: A Texas Population-Based Analysis. Cancer; Published Online: February 21, 2023 (DOI: 10.1002/cncr.34636).
  • McEvoy MT, Stuckert AJ, Castellanos MI, Gilbert MM, Pfeiffer T, Prudowsky ZD, Rios X, Airewele G, Okcu FM, Powers JM. Management of nutritional iron deficiency anemia for young children in the emergency department. Pediatr Blood Cancer. 2023; 70:e30181.
  • Castellanos MI, Dongarwar D, Wanser R, Caceres I, Park C, Rodriguez J, Salihu HM. In-hospital Mortality and Racial Disparity in Children and Adolescents With Acute Myeloid Leukemia: A Population-based Study. J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e114-e122. doi: 10.1097/MPH.0000000000002204. PubMed PMID: 34001781.
  • Dutta A, Ikwuezunma A, Castellanos MI, Brackett J, Reddy K, Mahajan P, Marshburn AM, Kamdar K, Paek H, Palazzi DL, Rabin KR, Scheurer ME, Gramatges MM. An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies. Pediatr Blood Cancer. 2021 Dec;68(12):e29228. doi: 10.1002/pbc.29228. Epub 2021 Jul 16. PubMed PMID: 34268879.
  • Castellanos MI, Lupo P, Oluyomi A, Gramatges MM, Scheurer M. Texas-Mexico Border Residence and Childhood Leukemia Survival: A Population-Based Analysis. American Society of Pediatric Hematology Oncology; 2021 April 21; Pediatric Blood & Cancer; c2021.
  • McEvoy MT, Prudowsky ZD, Stuckert AJ, Castellanos MM, Pfeiffer T, Rios X, Gilbert MM, Airewele G, Okcu FM, Powers JM. Practice Standard for Management of Nutritional Iron Deficiency Anemia in the Emergency Department. American Society of Pediatric Hematology Oncology; 2021 April 20; Pediatric Blood & Cancer; c2021.
  • Castellanos MI, Childress KJ, Ramirez M, Venkatramani R. Fetal exposure to capecitabine and temozolomide during the first trimester: A case report. J Gynecol Obstet Hum Reprod. 2020 Jul 23;:101881. doi: 10.1016/j.jogoh.2020.101881. [Epub ahead of print] PubMed PMID: 32712180.
  • Weatherspoon-Griffin N, Picker MA, Pew KL, Park HS, Ginete DR, Karney MM, Usufzy P, Castellanos MI, Duhart JC, Harrison DJ, Socea JN, Karabachev AD, Hensley CT, Howerton AJ, Ojeda-Daulo R, Immak JA, Wing HJ. Insights into transcriptional silencing and anti-silencing in Shigella flexneri: a detailed molecular analysis of the icsP virulence locus. Mol Microbiol. 2018 Jun;108(5):505-518. doi: 10.1111/mmi.13932. Epub 2018 Mar 23. PubMed PMID: 29453862; PubMed Central PMCID: PMC6311345.
  • Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS. Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leuk Lymphoma. 2013 Aug;54(8):1719-23. doi: 10.3109/10428194.2012.750724. Epub 2012 Dec 22. PubMed PMID: 23163568; PubMed Central PMCID: PMC3927453.
  • Kurukumbi M, Castellanos MI, Crawford AK, Gowdar SD, Jayam-Trouth A. Posterior Reversible Encephalopathy Syndrome in a Patient with Newly Diagnosed HIV Infection and End Stage Renal Disease. Case Rep Neurol Med. 2013;2013:473618. doi: 10.1155/2013/473618. Epub 2013 Apr 30. PubMed PMID: 23738165; PubMed Central PMCID: PMC3657446.
  • Castellanos MI, Harrison DJ, Smith JM, Labahn SK, Levy KM, Wing HJ. VirB alleviates H-NS repression of the icsP promoter in Shigella flexneri from sites more than one kilobase upstream of the transcription start site. J Bacteriol. 2009 Jun;191(12):4047-50. doi: 10.1128/JB.00313-09. Epub 2009 Apr 10. PubMed PMID: 19363111; PubMed Central PMCID: PMC2698392.

Go to UCSF Profiles, powered by CTSI